Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Generex signs letter of intent to buy 51% of Alfa Rhythm

Executive Summary

Drug delivery firm Generex Biotechnology Corp. signed a letter of intent to purchase 51% of start-up Alfa Rhythm Ltd., a privately held Israeli device firm, expanding the scope of Generex's business.
Deal Industry
  • Medical Devices
Deal Status
  • Preliminary
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Cash

Related Companies